Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Minerva Neurosciences, Inc - Common Stock (NQ:NERV)

2.020 -0.080 (-3.81%)
Streaming Delayed Price Updated: 10:44 AM EDT, Jul 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,913
Open 2.140
Bid (Size) 2.020 (2)
Ask (Size) 2.140 (3)
Prev. Close 2.100
Today's Range 2.020 - 2.140
52wk Range 1.150 - 3.300
Shares Outstanding 6,993,406
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
From Minerva Neurosciences, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga

Performance

YTD
-12.2%
-12.2%
1 Month
+17.4%
+17.4%
3 Month
+12.8%
+12.8%
6 Month
-14.8%
-14.8%
1 Year
-35.0%
-35.0%

More News

Read More
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates
From Minerva Neurosciences, Inc
Via GlobeNewswire
Minerva Neurosciences: Q4 Earnings Insights
Via Benzinga
Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates
From Minerva Neurosciences, Inc
Via GlobeNewswire
NERV Stock Earnings: Minerva Neurosciences Misses EPS for Q2 2024
Via InvestorPlace
Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates
From Minerva Neurosciences, Inc
Via GlobeNewswire
NERV Stock Earnings: Minerva Neurosciences Beats EPS for Q1 2024
Via InvestorPlace
Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
From Minerva Neurosciences, Inc
Via GlobeNewswire
Dow Dips Over 100 Points; J.M. Smucker Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Regulatory Setback For Minerva Neurosciences' Schizophrenia Treatment Candidate, FDA Asks For More Data
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Crude Oil Gains 1%; Macy's Plans To Close 150 Stores
Via Benzinga
Topics Stocks
Nasdaq Rises 50 Points; Lowe's Earnings Top Views
Via Benzinga
Topics Stocks
Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
From Minerva Neurosciences, Inc
Via GlobeNewswire
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
From Minerva Neurosciences, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates
From Minerva Neurosciences, Inc
Via GlobeNewswire
Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates
From Minerva Neurosciences, Inc
Via GlobeNewswire
10 Short Squeeze Stocks To Watch: Baosheng Media, Toro Corp, Getty Images And More
Via Benzinga
Top 5 Health Care Stocks That May Collapse This Quarter
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
Via Benzinga
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga

Frequently Asked Questions

Is Minerva Neurosciences, Inc - Common Stock publicly traded?
Yes, Minerva Neurosciences, Inc - Common Stock is publicly traded.
What exchange does Minerva Neurosciences, Inc - Common Stock trade on?
Minerva Neurosciences, Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Minerva Neurosciences, Inc - Common Stock?
The ticker symbol for Minerva Neurosciences, Inc - Common Stock is NERV on the Nasdaq Stock Market
What is the current price of Minerva Neurosciences, Inc - Common Stock?
The current price of Minerva Neurosciences, Inc - Common Stock is 2.020
When was Minerva Neurosciences, Inc - Common Stock last traded?
The last trade of Minerva Neurosciences, Inc - Common Stock was at 07/29/25 10:44 AM ET
What is the market capitalization of Minerva Neurosciences, Inc - Common Stock?
The market capitalization of Minerva Neurosciences, Inc - Common Stock is 14.13M
How many shares of Minerva Neurosciences, Inc - Common Stock are outstanding?
Minerva Neurosciences, Inc - Common Stock has 14M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.